Independent relationship between circulating resistin concentrations and endothelial activation in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 72, Issue 9, 2013, Pages 1586-1588

  Dessein, Patrick H ^a   Norton, Gavin R ^a   Woodiwiss, Angela J ^a   Solomon, Ahmed ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISONE; RESISTIN; RHEUMATOID FACTOR; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; CARDIOVASCULAR RISK; CLINICAL DISEASE ACTIVITY INDEX; DAS28; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASE; INFLAMMATION; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BODY WEIGHT; CHEMOKINE CCL2; ENDOTHELIAL CELLS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; RESISTIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84881479107     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203587     Document Type: Letter

References (10)

1. Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis. Circulation 2005;111:932-9.
2. Gomez R, Conde J, Scotece M, et al. What's new in our understanding of adipokines in rheumatic diseases? Nat Rev Rheumatol 2011;7:528-36.
3. Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, et al. Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol 2008;26:311-16. (Pubitemid 351659139)
4. Klaasen R, Herenius MM, Wijbrandts CA, et al. Treatment-specific changes in circulating adipocytokines: a comparison between tumor necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis 2012;71:1510-16.
5. Senolt L, Housa D, Vernerova Z, et al. Resistin in rheumatoid arthritis synovial tissue, synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007;66:458-63. (Pubitemid 46580464)
6. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789-95. (Pubitemid 40593223)
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
8. Solomon A, Norton GR, Woodiwiss AJ, et al. Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2012;14:R67.
9. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43. (Pubitemid 34212626)
10. Gu L, Okada Y, Clinton SK, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Molecular Cell 1998;2:275-81. (Pubitemid 128373654)